By Giorgio Minotti
Chapter 1 Mitochondrial disorder in phone damage and Cardiotoxicity (pages 1–23): Fabio Di Lisa, Martina Semenzato, Andrea Carpi, Sara Menazza, Nina Kaludercic, Roberta Menabo and Marcella Canton
Chapter 2 Cardiovascular Liabilities of substances: Regulatory elements (pages 25–45): Claudio Arrigoni
Chapter three mobile Mechanisms, Molecular goals, and Structure–Function Relationships in Drug?Induced Arrhythmias: Antihistamines, Psychoactive medicines, and Antimicrobial brokers (pages 47–96): Maria Virginia Soldovieri and Maurizio Taglialatela
Chapter four Cardiovascular Toxicity of Antitumor medicinal drugs: Dimensions of the matter in childrens (pages 97–126): Rebecca Scully and Steven E. Lipshultz
Chapter five Cardiovascular Toxicity of Antitumor medications: size of the matter in grownup Settings (pages 127–199): Joseph R. Carver and Chaitali J. Desai
Chapter 6 Diagnostic elements of Cardiovascular Toxicity of Antitumor medicinal drugs (pages 201–221): Michael S. Ewer and Thomas M. Suter
Chapter 7 Cardiovascular Toxicity of Antitumor medications: Translating Molecular Mechanisms into medical proof (pages 223–256): Pierantonio Menna, Emanuela Salvatorelli, Carlo Salsano, Luca Gianni and Giorgio Minotti
Chapter eight NSAID motion and the principles for Cardiovascular Toxicity (pages 257–285): Anna L. Blobaum and Lawrence J. Marnett
Chapter nine Cardiovascular Toxicities of NSAIDS: Epidemiologic elements (pages 287–312): Antonio Gonzalez?Perez and Luis Alberto Garcia Rodriguez
Chapter 10 Cardiovascular Toxicities of Life?Saving medicines: Antiviral remedy (pages 313–332): James J. Kohler and William Lewis
Read or Download Cardiotoxicity of Non-Cardiovascular Drugs PDF
Best cardiovascular books
Written for pediatric cardiologists who are looking to specialise in interventional cardiology and wish a step by step consultant to accomplishing tactics, this functional textual content can also be geared toward grownup cardiologists who are looking to study greater than simply 'shooting for the coronaries'. Addressing this desire, all types of interventions in congenital middle ailment and the recent box of 'structural middle ailment' are coated, together with ·acquired valvular middle affliction ·post-myocardial infarction ventricular septal defects ·PFO closure ·closure of the left atrial appendage ·paravalvular leak closure ·techniques to regard ailments of the aorta ·hybrid approaches the one contemporary textual content on easy methods to practice interventional cardiology for congenital middle illness in either the pediatric and grownup sufferer, this expertly written paintings can help to beat limitations among pediatric and grownup cardiologists, and pave the best way for a brand new expert, the cardiovascular interventionalist.
It is a 3-in-1 reference ebook. It provides an entire scientific dictionary overlaying countless numbers of phrases and expressions in terms of hemophilia. It additionally offers huge lists of bibliographic citations. eventually, it offers details to clients on the way to replace their wisdom utilizing quite a few net assets.
Weak plaque improvement is the results of a posh sequence of molecular and mobile occasions related to irritation, apoptosis, rupture, and thrombosis. a close knowing of the mechanisms underlying the improvement of high-risk plaques, besides the power to imagine and diagnose those susceptible lesions, will result in the powerful administration of acute coronary syndromes.
Edited via one of many world's prime interventional cardiologists and educators, this new publication is created with an eye fixed on giving the reader a high-quality, useful and clinically-focused knowing of this crucial classification of substances, from uncomplicated technology to a clear-headed dialogue of advanced issues equivalent to blend treatments, drug-drug interactions, and platelet resistance.
- Échocardiographie pédiatrique et foetale
- The ESC Textbook of Preventive Cardiology: Clinical practice
- Cardiovascular Intervention: A Companion to Braunwald's Heart Disease
- Handbook of coronary stents
Additional info for Cardiotoxicity of Non-Cardiovascular Drugs
52. C. Shih, K. J. Ridd, Monoamine oxidase: from genes to behavior, Annu. Rev. , 22, 197–217 (1999). 53. E. J. Davies, Mitochondrial free radical generation, oxidative stress, and aging, Free Radic. Biol. , 29, 222–230 (2000). 54. P. Bianchi, O. Kunduzova, E. , Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury, Circulation, 112, 3297–3305 (2005). 55. A. Carpi, R. Menabo`, N. , The cardioprotective effects elicited by p66(Shc) ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury, Biochim.
T. Ide, H. Tsutsui, S. Kinugawa, N. , Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium, Circ. , 86, 152–157 (2000). 41. D. Cesselli, I. Jakoniuk, L. , Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy, Circ. , 89, 279–286 (2001). 42. M. Rota, N. Lecapitaine, T. , Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene, Circ.
258, C755–786 (1990). 16. P. Bernardi, Mitochondrial transport of cations: channels, exchangers, and permeability transition, Physiol. , 79, 1127–1155 (1999). 17. N. Weiss, P. M. Honda, and P. Ping, Role of the mitochondrial permeability transition in myocardial disease, Circ. , 93, 292–301 (2003). 18. P. J. A. Javadov, Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection, Cardiovasc. , 61, 372–385 (2004). 18 MITOCHONDRIAL DYSFUNCTION IN CELL INJURY 19.